IN RE GALENA BIOPHARMA, INC.

www.GalenaBiopharmaStockholderSettlement.com


WELCOME TO THE GALENA BIOPHARMA STOCKHOLDER SETTLEMENT WEBSITE

In re Galena Biopharma, Inc., Delaware Court of Chancery, C.A. No. 2017-0423-JTL.

Class Members include all Galena common stockholders who were entitled to vote at Galena’s 2016 annual meeting held on July 14, 2016; Galena’s 2016 special meeting held on October 21, 2016; and/or Galena’s 2017 special meeting held on July 6, 2017. If approved by the Court, disbursements will be made to Eligible Class Members who held stock on the record date for Galena’s 2016 Special Meeting. For additional details regarding this Settlement, how your rights will be affected by the legal proceedings in this Action, and the distribution of the Net Settlement Fund if approved by the Court, please read the Notice and proposed Plan of Allocation.

This website is not an expression of any opinion by the Court concerning the merits of any claim in the Action, and the Court still has to decide whether to approve the Settlement. If the Court approves the Settlement and a plan of allocation, then payments to Eligible Class Members will be made after any appeals are resolved.

Notice

Learn more about the Settlement by downloading the Notice in this case.

Court Documents

Learn more about the Settlement by downloading the documents below.

Contact

Inquiries or comments about the Settlement, other than requests for additional copies of the Notice, may be directed to the attention of Plaintiff’s Counsel as follows:

Ronald A. Brown, Jr., Esquire Kevin H. Davenport, Esquire Eric J. Juray, Esquire Prickett, Jones & Elliott, P.A. 1310 North King Street Wilmington, Delaware 19801